Time to Hospital Evaluation in Patients of Acute Stroke for Alteplase Therapy

Size: px
Start display at page:

Download "Time to Hospital Evaluation in Patients of Acute Stroke for Alteplase Therapy"

Transcription

1 1 Original Article Time to Hospital Evaluation in Patients of Acute Stroke for Alteplase Therapy Asad Mahmood,* Muhammad Ashraf Sharif,** Umar Zafar Ali,* Muhammad Naeem Khan* From *Military Hospital (MH), Rawalpindi and **Armed Forces Institute of Pathology, Rawalpindi. Correspondence: Dr. Muhammad Ashraf Sharif, House No: 107, Street: 110 Sector G-11/3, Islamabad. Tel: Received: April 12, 2008 Accepted: October 25, 2008 ABSTRACT Objective: To determine the time from onset of symptoms to hospital evaluation in patients with acute cerebro-vascular accidents to assess their eligibility for thrombolytic therapy. Materials and Methods: This cross sectional observational study was carried out from March 2004 to September 2004 at the Department of Neurology, Military Hospital, Rawalpindi on 95 patients with acute cerebro-vascular accident. Patients of stroke presenting in outpatient and emergency department within 72 hours of onset of symptoms were included in the study. NIH Stroke Scale (NIHSS) was assessed at time of admission and all had CT scan. Time of onset of symptoms, arrival at ER/OPD to time taken by resident or neurologist in attending patient and time of getting CT scan were noted. Results: Of 95 patients, 20 (21%) were hemorrhagic and 75 (79%) were ischemic in nature. Median time of arrival to hospital from onset of symptoms was 12hrs (range 1-72hrs). Median time taken by resident to attend patient was 10min (range 2-30mins). CT brain was performed within 90min (range ) after arrival in hospital. Arrival within 1

2 2 3 hours of symptoms was seen in 16 (16.8%) patients, 13 (13.7%) patients within 6hrs while 66 (69.5%) patients after 6hrs. When adjusted for hospital delay and excluding the patients with hemorrhagic infarcts, 4 (4.2%) patients arrived within 3hrs and were most appropriate candidates for thrombolytic therapy. There were 11 (11.6%) patients assessed within 6hrs while the majority 80 (84.2%) came after 6hrs. Conclusion: Most patients with stroke do not reach hospital in time and are not suitable candidates for thrombolytic therapy. (Rawal Med J 2009;34:43-46). Key Words: Stroke, cerebrovascular accident, thrombolytic therapy. INTRODUCTION Stroke is the third main cause of death and the leading cause of long term disability. 1 In the United States alone approximately 750,000 strokes occur annually with mortality rate exceeding 150, In Pakistan, India, China, Nepal, Sri Lanka and Thailand there has been increase in stroke mortality due to increased risk factors and poor socioeconomic and health system. 3 A National Health Survey carried out at Aga Khan University, Pakistan, identified 33% prevalence of hypertension in adult population, with 2 million diabetics and 20% population of smokers or tobacco users. 4 Despite the approval of thrombolytic therapy for ischemic stroke in 1996 by FDA, the number of patients benefiting from it have been small. 5-6 Those benefited the most were who reported within a narrow therapeutic window limited to 3 hours only. 7 However, only 1% to 2% of patients with ischemic stroke are estimated to be treated within 3 hrs in various centers with maximum of 5% in selected centers. 5,8 Failure to reach the hospital in time is the main reason in majority of patients and therefore has been extensively 2

3 3 studied all over the world In Pakistan, due to low level of awareness and general education, rampant alternative therapies and lack of adequate health transport system, the time to seek treatment is especially prolonged. Earlier local studies have shown prehospital delay of 6-9 hours in the majority of the patients. 15,16 The objective of this study was to evaluate the time that patients take to reach hospital from the onset of symptoms and the emergency evaluation till the final diagnosis of stroke so as to assess the feasibility of thrombolytic therapy. MATERIALS AND METHODS This study was conducted at Military Hospital, Rawalpindi from 21 st March 2004 to 23 rd September Stroke was defined as rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hrs or leading to death, confirming to a vascular territory and without other evident cause. Patients with age >18 years and symptoms of less than 72 hours were included in the study. Those who had recurrent strokes were excluded from the study. Clinical diagnosis was established, NIHSS score was calculated and CT brain was performed in all patients. Time of onset was ascertained from patients or relatives. Symptom onset time was defined as the time when the patient first became aware of the symptoms. For patients who woke up with symptoms, time of onset was taken as time at which patient went to sleep and for those who were admitted unconscious; time of onset was taken as the last time they were witnessed to be well. Time of arrival to the hospital and time taken by a resident to attend the patient was endorsed on the predesigned proforma. Time of CT scan was noted from the record film. 3

4 4 Pre-hospital delay was defined as the time from onset of symptoms till arrival in the ER/OPD. In-hospital delay included time taken for visit by an internist and till the time CT scan is done. Total time delay included the pre-hospital and in-hospital time and was a measure of eligibility for thrombolytic therapy. Data was entered into SPSS v Median time interval for both pre hospital and in-hospital delay was calculated with minimum and maximum range. The pre-hospital time was divided into three groups as patients arriving within 3hrs, within 6hrs and after 6hrs. RESULTS A total of 95 patients fulfilled the inclusion criteria and 79% were males and 21% females. Mean age was 62 years (range 34-85). Ischemic stroke was more common (78.9%) as compared to hemorrhagic stroke (21.1%). Most of the patients were brought to hospital in a taxi (67.4%) as compared to ambulance (14.7%) or private car (17.9%). The median pre-hospital delay time was 12hrs with a range of 1 to 72hrs. Mean prehospital delay was 19hrs. Approximate 17% arrived to hospital within 3hrs, 14% arrived within 6hrs and rest of the subjects (69%) came after 6hrs (Figure 1). Fig 1. Pre hospital time delay in patients with stroke (n=95). 4

5 Within 3 hours Within 6 hours After 6 hours 0 Within 3 hours Within 6 hours After 6 hours The median time delay to attend by a resident was 10 min with a range of 2 min to 30 min. Mean time delay was 12 min. CT scan brain was performed with a median time delay of 90min with range from 10 to 390min. Mean time interval was 117min (approx 2hrs). When adjusted for in-hospital delay and excluding the patients with hemorrhagic stroke who arrived early, patients with a total delay time of less than 3hrs were only 4.2%, as compared to those who arrived in less than 6hrs (11.6%). Patients coming later than 6hrs were 84.2% (Figure 2). 5

6 6 Fig 2. Pre hospital time delay in patients with ischemic stroke (n=75) <3 hours < 6 hours > 6 hours This reflects that although 17% of patients arrived within 3 hrs yet only 4.2% were true candidates for thrombolytic therapy and out of the rest 12.8%, 4.2% had hemorrhagic stroke while 8.6% accounted for in-hospital delay. DISCUSSION Studies of cerebral blood flow measurement based upon Kety-Schmidt principle have revealed that after occlusion of an artery there is region of brain that is threatened but viable and it was termed the ischemic penumbra and the time this zone would remain viable was called therapeutic time window. Though degree of occlusion, presence of collaterals and extent of spontaneous reperfusion can vary, animal studies have 6

7 7 consistently shown that reperfusion within 3 hours of arterial occlusion will limit the size of infarct and improve the outcome. 17 This scientific dictum has given origin to the concept of time delay which has been defined as time it takes from stroke onset to initiation of acute medical intervention. As the first step, we have tried to establish delay time in our community. Around 17% of patients arrived within 3 hours and further 14% arrived within 6 hours of onset of symptoms, a result which is far from ideal. The mean pre-hospital delay in the present study was 5.4 hours with a total of 56% patients arriving within 3 hours. This time lapse is similar to earlier studies by Basharat et al 15 and Siddiqui et al 16 in Pakistan. The mean time delay for CT scan in Genentech Stroke Presentation Survey was 1.9 hours. 18 A similar result was reported by a UK based study which identified that 37% patients reported within 3 hours and 50% in 6hours. 19 Stroke unit admission were shown to be 29% in 3 hours and 75% within 6 hours in a French stroke unit basically due to Emergency Medical Services and Fire Department ambulances. 12 In Beijing China, median time from onset to ED was 5.17 hours and time for CT was 10 minutes with 78.2% of patients treated within one hour. 13 At a center in New Delhi India 25% of patients were admitted within 3hours of symptom onset, a result comparable to our population but they had significant higher percentage at 6 hours (49%). 14 Although the present study did not address the factors causing the time delay, lack of awareness, low threat perception, non-availablility of ambulance services and contact with local general practitioner have been attributed for this delay in previous studies. 15,16 In conclusion, only 17% stroke patient arrived at hospital within three hours of onset of symptoms. Efforts should be made to reduce the delays at all levels. With poor socio- 7

8 8 economic structure, low level of education and awareness, lack of health services and rising incidence of risk factors for stroke, the need seems to be all the more important. REFERENCES 1. Bonita R. Epidemiology of stroke. Lancet. 1992;339: Thom T, Haase N, Rosamond W, Howard VJ, John Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2006;113: Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens.2000;14: Pakistan Medical Research Council, National Health Survey of Pakistan. Health profile of the people of Pakistan. 1998, pp Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke.1998;29: NINDS t-pa Stroke Study Group. Generalized efficacy of t-pa for acute stroke: subgroup analysis of the NINDS t-pa Stroke Trial. Stroke.1997;28: Marler JR, Tilley BC, Lu M, Broderick J, Brott T, Lyden P, et al. Early stroke treatment associated with better outcome: the NINDS rt-pa stroke study. Neurology.2000;55:

9 9 8. Engelstein E, Margulies J, Jeret JS. Lack of t-pa use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria. Am J Emerg Med.2000: 18: Smith MA, Doliszny KM, Shahar E, Mcgovern PG, Arnett DK, Luepker RV. Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med.1998;129: Morris D, Rosamond W, Hinn A, Gorton R. Time delays in accessing stroke care in the emergency department. Acad Emerg Med.1999;6: Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: stroke time registry for outcomes knowledge and epidemiology (S.T.R.O.K.E.). Stroke.2001;32: Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors influencing early stroke admission in French stroke unit. Stroke. 2002;33: Wang S, Niu S, Wang Y, Zhang G. Evaluation of the factors leading to delay from stroke onset to arrival at hospital. Zhonghua Nei Ke Za Zhi.2002;41: Srivastava AK, Prasad K. A study of factors delaying hospital arrival of patients with acute stroke. Neurol India.2001;49: Basharat RA, Mirza KR, Qamar MY. Delay in presentation of acute ischemic stroke in Lahore General Hospital, Lahore. Ann King Edward Med Coll. 2005;11: Siddiqui M, Siddiqui SR, Zafar A, Khan FS. Factors delaying hospital arrival of patients with acute stroke. J Pak Med Assoc.2008;58:

10 Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54: Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke. The Genentech Stroke Presentation Survey. Stroke 2000;31: Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. Brit Med J 2002;325:17. 10

11 11 11

A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke

A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke Hong Kong Journal of Emergency Medicine A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke YH Yun, JY Chung, MJ Kang, JT

More information

Factors Influencing Pre-Hospital Delay after Ischemic Stroke and Transient Ischemic Attack

Factors Influencing Pre-Hospital Delay after Ischemic Stroke and Transient Ischemic Attack ORIGINAL ARTICLE Factors Influencing Pre-Hospital Delay after Ischemic Stroke and Transient Ischemic Attack Yuko Tanaka 1, Makoto Nakajima 1, Teruyuki Hirano 2 and Makoto Uchino 2 Abstract Background and

More information

Thrombolytic therapy can improve neurological outcomes

Thrombolytic therapy can improve neurological outcomes Prehospital Notification by Emergency Medical Services Reduces Delays in Stroke Evaluation Findings From the North Carolina Stroke Care Collaborative Mehul D. Patel, MSPH; Kathryn M. Rose, PhD; Emily C.

More information

The administration of intravenous tissue plasminogen

The administration of intravenous tissue plasminogen Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke A Canadian Hospital s Experience Kristine M. Chapman, MD; Andrew R. Woolfenden, MD; Douglas Graeb, MD; Dean C.C. Johnston, MD; Jeff Beckman,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wolters FJ, Li L, Gutnikov SA, Mehta Z, Rothwell PM. Medical attention seeking after transient ischemic attack and minor stroke in relation to the UK Face, Arm, Speech, Time

More information

Presentation Time to Hospital and Recognition of Stroke in Patients with Ischemic Stroke

Presentation Time to Hospital and Recognition of Stroke in Patients with Ischemic Stroke Presentation Time to Hospital and Recognition of Stroke in Patients with Ischemic Stroke Ji Hoe Heo, M.D., Hwa Young Cheon, M.D., Chung Mo Nam, Ph.D.*, Dong Chan Kim, R.N., Gyung Whan Kim, M.D., Byung

More information

Mechanical thrombectomy in Plymouth. Will Adams. Will Adams

Mechanical thrombectomy in Plymouth. Will Adams. Will Adams Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Endovascular Treatment for Acute Ischemic Stroke

Endovascular Treatment for Acute Ischemic Stroke ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1

More information

STROKE is a major cause of disability and

STROKE is a major cause of disability and 218 STROKE DELAYS Morris et al. STROKE CARE DELAYS EDUCATION AND PRACTICE Time Delays in Accessing Stroke Care in the Emergency Department DEXTER L. MORRIS, PHD, MD, WAYNE D. ROSAMOND, PHD, ALBERT R. HINN,

More information

Making every second count Challenges in acute stroke management Prehospital management of acute ischaemic stroke: how can we do better?

Making every second count Challenges in acute stroke management Prehospital management of acute ischaemic stroke: how can we do better? Making every second count Challenges in acute stroke management Prehospital management of acute ischaemic stroke: how can we do better? Patrick Goldstein, MD, Lille, France NIH-recommended emergency department

More information

Rural emergency department best practice for treatment of acute ischemic stroke

Rural emergency department best practice for treatment of acute ischemic stroke Rural emergency department best practice for treatment of acute ischemic stroke Aubrey J. Hoye, DO Ministry Howard Young Medical Center, Woodruff, WI Ministry Eagle River Memorial Hospital, Eagle River,

More information

Thrombolytic Therapy in Clinical Practice The Norwegian Experience

Thrombolytic Therapy in Clinical Practice The Norwegian Experience Thrombolytic Therapy in Clinical Practice The Norwegian Experience Thomassen Lars Thomassen, Ulrike Waje-Andreassen, Halvor Næss ABSTRACT Background: Awaiting the European approval of thrombolysis, we

More information

Factors Delaying Hospital Arrival after Acute Stroke in Southern Taiwan. Teng-Yeow Tan, MD; Ku-Chou Chang, MD; Chia-Wei Liou, MD

Factors Delaying Hospital Arrival after Acute Stroke in Southern Taiwan. Teng-Yeow Tan, MD; Ku-Chou Chang, MD; Chia-Wei Liou, MD Original Article 458 Factors Delaying Hospital Arrival after Acute Stroke in Southern Taiwan Teng-Yeow Tan, MD; Ku-Chou Chang, MD; Chia-Wei Liou, MD Background: Acute stroke management emphasizes prompt

More information

Thrombolysis with recombinant tissue plasminogen activator

Thrombolysis with recombinant tissue plasminogen activator Delay in Presentation After an Acute Stroke in a Multiethnic Population in South London: The South London Stroke Register Juliet Addo, PhD; Salma Ayis, PhD; Josette Leon, BSc; Anthony G. Rudd, FRCP; Christopher

More information

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center

More information

Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina

Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina ISRN Stroke, Article ID 313976, 4 pages http://dx.doi.org/10.1155/2014/313976 Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina DDevdet SmajloviT,DenisaSalihoviT,

More information

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 NEW STUDIES FOR 2015 MR CLEAN ESCAPE EXTEND-IA REVASCAT SWIFT PRIME RECOGNIZED LIMITATIONS IV Alteplase proven benefit

More information

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke Original Article Medical Journal of the Islamic Republic of Iran, Vol. 27, No. 3, Aug 2013, pp. 113-118 Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic

More information

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service) Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation

More information

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

COMPREHENSIVE SUMMARY OF INSTOR REPORTS COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list

More information

Frequency of Cardiac Risk Factors in. Ischemic

Frequency of Cardiac Risk Factors in. Ischemic Frequency of Cardiac Risk Factors in Ischemic Stroke CORRESPONDING AUTHOR: MUSHTAQUE AHMED, MD EMAIL: BUGHIOAHMED@GMAIL.COM NEW YORK PRESBYTERIAN WEILL CORNELLL MEDICAL COLLEGE, NY ABSTRACT Stroke is the

More information

Awareness of stroke among stroke patients in a tertiary-care level hospital in northwest India

Awareness of stroke among stroke patients in a tertiary-care level hospital in northwest India Research Article Awareness of stroke among stroke patients in a tertiary-care level hospital in northwest India Sulena Sulena, Banshi Lal Kumawat, Anjani Kumar Sharma Department of Neurology, SMS Medical

More information

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018 Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy

More information

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE 2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American

More information

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Stroke Update 2015 Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Objectives 1. Review successes in systems of care approach to acute ischemic stroke

More information

Article ID: WMC ISSN

Article ID: WMC ISSN Article ID: WMC004795 ISSN 2046-1690 Correlation of Alberta Stroke Program Early Computed Tomography Score on CT and Volume on Diffusion Weighted MRI with National Institutes of Health Stroke Scale Peer

More information

Disclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!

Disclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency! Disclosures Anesthesia for Endovascular Treatment of Acute Ischemic Stroke I have nothing to disclose. Chanhung Lee MD, PhD Associate Professor Anesthesia and perioperative Care Acute Ischemic Stroke 780,000

More information

Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations 1

Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations 1 James E. Stahl, MD, CM, MPH Karen L. Furie, MD Suzanne Gleason, PhD G. Scott Gazelle, MD, MPH, PhD Index terms: Brain, infarction, 13.78 Cost-effectiveness Economics, medical Radiology and radiologists,

More information

Role of recombinant tissue plasminogen activator in the updated stroke approach

Role of recombinant tissue plasminogen activator in the updated stroke approach Role of recombinant tissue plasminogen activator in the updated stroke approach Joshua Z. Willey, MD, MS Assistant Professor of Neurology Division of Stroke, Columbia University October 2015 jzw2@columbia.edu

More information

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular

More information

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University

More information

Parameter Optimized Treatment for Acute Ischemic Stroke

Parameter Optimized Treatment for Acute Ischemic Stroke Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,

More information

NHL Journal of Medical Sciences/July 2014/Vol 3/Issue 2 18

NHL Journal of Medical Sciences/July 2014/Vol 3/Issue 2 18 Research article NIHSS Score: A handy tool to predict vascular occlusion in acute ischemic stroke Ronak Shah*, Chintal Vyas**, Jyoti Vora*** *Senior Resident, **Assistant Professor, ***Associate Professor,

More information

Latest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G

Latest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G Latest Advances in the Neurointerventional Treatment of Ischemic Stroke Neurointerventional Management of Ischemic Stroke 1. Thrombectomy for acute ischemic stroke 2. Carotid artery stenting 3. Management

More information

Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke

Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke Research Article imedpub Journals http://www.imedpub.com Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke Abstract Background: The number of patients who are adopted

More information

Acute ischemic stroke is a major cause of morbidity

Acute ischemic stroke is a major cause of morbidity Outcomes of Treatment with Recombinant Tissue Plasminogen Activator in Patients Age 80 Years and Older Presenting with Acute Ischemic Stroke Jennifer C. Drost, DO, MPH, and Susana M. Bowling, MD ABSTRACT

More information

Stroke remains the third leading cause of death and the

Stroke remains the third leading cause of death and the Stroke Symptoms and the Decision to Call for an Ambulance Ian Mosley, MBus; Marcus Nicol, PhD; Geoffrey Donnan, MD; Ian Patrick, ASM; Helen Dewey, PhD Background and Purpose Few acute stroke patients are

More information

7 TI - Epidemiology of intracerebral hemorrhage.

7 TI - Epidemiology of intracerebral hemorrhage. 1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral

More information

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec

More information

IMAGING IN ACUTE ISCHEMIC STROKE

IMAGING IN ACUTE ISCHEMIC STROKE IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;

More information

Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know?

Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know? Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center What do we know? Stroke: Time is Brain Shorter onset to treatment times

More information

Endovascular Treatment Updates in Stroke Care

Endovascular Treatment Updates in Stroke Care Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine

More information

10/26/2016. Disclosures. Mobile Stroke Units

10/26/2016. Disclosures. Mobile Stroke Units Mobile Stroke Units Andrei V. Alexandrov, MD Semmes-Murphey Professor and Chairman Department of Neurology Medical Director, Mobile Stroke Unit, UT Clinical Health Memphis, TN Disclosures Funding: Assisi

More information

: STROKE. other pertinent information such as recent trauma, illicit drug use, pertinent medical history or use of oral contraceptives.

: STROKE. other pertinent information such as recent trauma, illicit drug use, pertinent medical history or use of oral contraceptives. INTRODUCTION A cerebral vascular accident (CVA) or stroke is a lack of blood supply to the brain as a result of either ischemia or hemorrhage. 80% of CVAs are a result of ischemia (embolic or thrombotic)

More information

A STUDY TO DETERMINE THE FACTORS ASSOCIATED WITH HOSPITAL ARRIVAL TIME FOR STROKE PATIENTS IN SCTIMST

A STUDY TO DETERMINE THE FACTORS ASSOCIATED WITH HOSPITAL ARRIVAL TIME FOR STROKE PATIENTS IN SCTIMST A STUDY TO DETERMINE THE FACTORS ASSOCIATED WITH HOSPITAL ARRIVAL TIME FOR STROKE PATIENTS IN SCTIMST PROJECT REPORT Submitted in partial fulfillment of the requirements For the Diploma in Neuro Nursing

More information

Maximising Delivery of Thrombectomy

Maximising Delivery of Thrombectomy Maximising Delivery of Thrombectomy Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor of Clinical

More information

Code Stroke in real life. Disclosures. Parkland Memorial Hospital. I have no disclosures. Has 1 million patient visits annually. Level 1 Trauma Center

Code Stroke in real life. Disclosures. Parkland Memorial Hospital. I have no disclosures. Has 1 million patient visits annually. Level 1 Trauma Center Code Stroke in real life Alejandro Magadán, M.D. University of Texas Southwestern Medical Center Medical Director for Stroke Parkland Memorial Hospital Disclosures I have no disclosures Parkland Memorial

More information

11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care

11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment

More information

First Year of 24/7 ASU and Stroke Thrombolytic Service

First Year of 24/7 ASU and Stroke Thrombolytic Service First Year of 24/7 ASU and Stroke Thrombolytic Service Kwan M, Chang C, Mak W, Ip F, Chang R, Pang S, Hon S, Ho SL, Cheung RTF Division of Neurology, Department of Medicine, Queen Mary Hospital. IV Thrombolysis

More information

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014 ND STROKE Coordinators Case Studies STEMI and Stroke Conference, Fargo, ND, August 5, 2014 STROKE Coordinator Case Study Essentia Health, Fargo Essentia Health Stroke Alert Process Within 24 hours of Last

More information

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with

More information

How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage

How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient

More information

BY: Ramon Medina EMT-LP/RN

BY: Ramon Medina EMT-LP/RN BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management

More information

Acute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center

Acute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting

More information

HERMES Time and Workflow Primary Paper. Statistical Analysis Plan

HERMES Time and Workflow Primary Paper. Statistical Analysis Plan HERMES Time and Workflow Primary Paper Statistical Analysis Plan I. Study Aims This is a post-hoc analysis of the pooled HERMES dataset, with the following specific aims: A) To characterize the time period

More information

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS

More information

ORIGINAL CONTRIBUTION. Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke

ORIGINAL CONTRIBUTION. Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke Houston Experience 1996 to 2000 ORIGINAL CONTRIBUTION James C. Grotta, MD; W. Scott Burgin, MD; Ashraf El-Mitwalli, MD; Megan Long;

More information

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018 Stroke Update Claire J. Creutzfeldt, MD January 12, 2018 Disclosures None relevant to this presentation I receive funding from the NINDS What s new in stroke? A new model for cardioembolic stroke: atrial

More information

Building a Stroke Portfolio. June 28, 2018

Building a Stroke Portfolio. June 28, 2018 Building a Stroke Portfolio June 28, 2018 1 Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to: the potential benefits, safety and efficacy

More information

Prevalence and Characteristics of Stroke in Internally Displaced Peoples Admitted to a Hospital in Bannu

Prevalence and Characteristics of Stroke in Internally Displaced Peoples Admitted to a Hospital in Bannu Original Article Prevalence and Characteristics of Stroke in Internally Displaced Peoples Admitted to a Hospital in Bannu Abdul Razzaq 1, Tehsinullah 2, Wasim Ahmed 3, Mohammad Nadeem Khan 4, Mohammad

More information

Advances in Neuro-Endovascular Care for Acute Stroke

Advances in Neuro-Endovascular Care for Acute Stroke Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center

More information

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Protocol for IV rtpa Treatment of Acute Ischemic Stroke Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and

More information

Broadening the Stroke Window in Light of the DAWN Trial

Broadening the Stroke Window in Light of the DAWN Trial Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University

More information

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012 Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model

More information

Updated tpa Guidelines: Expanding the opportunity for good outcomes. Benjamin Morrow, MSN RN UPMC Stroke Institute

Updated tpa Guidelines: Expanding the opportunity for good outcomes. Benjamin Morrow, MSN RN UPMC Stroke Institute Updated tpa Guidelines: Expanding the opportunity for good outcomes Benjamin Morrow, MSN RN UPMC Stroke Institute 1 Outline History Current State Review Exclusions: Minor stroke symptoms Severe strokes

More information

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

TENNESSEE STROKE REGISTRY QUARTERLY REPORT TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 3 September 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender

More information

Stroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA

Stroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American

More information

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

TENNESSEE STROKE REGISTRY QUARTERLY REPORT TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 2 July 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender distributions,

More information

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on 6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

More information

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy Updates in Stroke Management Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy Disclosure I have no actual or potential conflict of interest

More information

Stroke Thrombolysis. Dr Peter Anderton (Stroke Consultant DBTH)

Stroke Thrombolysis. Dr Peter Anderton (Stroke Consultant DBTH) Stroke Thrombolysis Dr Peter Anderton (Stroke Consultant DBTH) Thrombolysis for ischaemic stroke Rationale Restoration of blood flow Salvage of ischaemic penumbra Schematic of the mismatch model for defining

More information

Comparison of outcome of etiological factors for non-traumatic coma in geriatric population in India

Comparison of outcome of etiological factors for non-traumatic coma in geriatric population in India Original article: Comparison of outcome of etiological factors for non-traumatic coma in geriatric population in India 1 DrAmit Suresh Bhate, 2 DrSatishNirhale, 3 DrPrajwalRao, 4 DrShubangi A Kanitkar

More information

Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur

Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur Original article Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur 1 Dr. Dr.Uday Shankar Sanakayala, 2 Dr. T. V. Adi Seshu Babu, 3 Dr.

More information

JMSCR Vol 3 Issue 12 Page December 2015

JMSCR Vol 3 Issue 12 Page December 2015 www.jmscr.igmpublication.org Impact Factor 3.79 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v3i12.07 Study of Lipid Profile in Ischemic Cerebrovascular

More information

Symptomatic intracerebral hemorrhage (sich) after

Symptomatic intracerebral hemorrhage (sich) after Reduced Pretreatment Ipsilateral Middle Cerebral Artery Cerebral Blood Flow Is Predictive of Symptomatic Hemorrhage Post Intra-Arterial Thrombolysis in Patients With Middle Cerebral Artery Occlusion Rishi

More information

framework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow

framework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow Acute Stroke Treatment Collaterals in Acute Ischemic Stroke Objectives role of collaterals in acute ischemic stroke collateral therapeutic strategies David S Liebeskind, MD Professor of Neurology & Director

More information

The International Journal of Neuroscience

The International Journal of Neuroscience The Underlying Factor Structure of National Institutes of Health Stroke Scale: An Exploratory Factor Analysis Journal: The International Journal of Neuroscience Manuscript ID: GNES-0-0 Manuscript Type:

More information

Mohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD*

Mohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD* Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Mohamed Al-Khaled,

More information

Intravenous thrombolysis in acute ischemic stroke our experience

Intravenous thrombolysis in acute ischemic stroke our experience Romanian Neurosurgery (2017) XXXI 2: 137-145 137 DOI: 10.1515/romneu-2017-0021 Intravenous thrombolysis in acute ischemic stroke our experience Tudor Cuciureanu 1, Diana Hodorog 2,3, Iulian Dan Cuciureanu

More information

Acute Stroke Treatment: Current Trends 2010

Acute Stroke Treatment: Current Trends 2010 Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment

More information

Stroke Net Grand Round Webinar

Stroke Net Grand Round Webinar Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review

More information

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in

More information

Acute stroke management has changed over the past 10

Acute stroke management has changed over the past 10 Emergency Calls in Acute Stroke René Handschu, MD; Reinhard Poppe; Joachim Rauß; Bernhard Neundörfer, MD, PhD; Frank Erbguth, MD, PhD Background and Purpose In the last 10 years, stroke has become a medical

More information

Acute Ischaemic Stroke Pathways Drip and Ship

Acute Ischaemic Stroke Pathways Drip and Ship Acute Ischaemic Stroke Pathways Drip and Ship Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor

More information

Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke. Kenneth V Snyder MD PhD SUNY Buffalo, NY

Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke. Kenneth V Snyder MD PhD SUNY Buffalo, NY Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke Kenneth V Snyder MD PhD SUNY Buffalo, NY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Honorarium

More information

FREQUENCY OF COMMON MODIFIABLE RISK FACTORS FOR STROKE

FREQUENCY OF COMMON MODIFIABLE RISK FACTORS FOR STROKE ORIGINAL ARTICLE FREQUENCY OF COMMON MODIFIABLE RISK FACTORS FOR STROKE Ashok Kumar Lahano, Mujahid Ali Chandio, Muhammad Irfan Bhatti Department of Medicine, Peoples University Hospital, Shaheed Benazirabad

More information

MAGNETIC RESONANCE IMAGING CRITERIA FOR THROMBOLYSIS IN HYPERACUTE CEREBRAL INFARCTION IN KOSOVA

MAGNETIC RESONANCE IMAGING CRITERIA FOR THROMBOLYSIS IN HYPERACUTE CEREBRAL INFARCTION IN KOSOVA UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL MAGNETIC RESONANCE IMAGING CRITERIA FOR THROMBOLYSIS IN HYPERACUTE CEREBRAL INFARCTION IN KOSOVA PhD THESIS ABSTRACT PhD SUPERVISOR, PROFESSOR

More information

Patient characteristics. Intervention Comparison Length of followup. Outcome measures. Number of patients. Evidence level.

Patient characteristics. Intervention Comparison Length of followup. Outcome measures. Number of patients. Evidence level. 5.0 Rapid recognition of symptoms and diagnosis 5.1. Pre-hospital health professional checklists for the prompt recognition of symptoms of TIA and stroke Evidence Tables ASM1: What is the accuracy of a

More information

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe Dong-Wha Kang, MD, PhD; Julio A. Chalela, MD; William Dunn, MD; Steven Warach, MD, PhD; NIH-Suburban Stroke Center

More information

ACUTE STROKE IMAGING

ACUTE STROKE IMAGING ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University

More information

Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke

Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/23 Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke B Balaji 1, Bingi Srinivas 2 1 Associate Professor,

More information

Comparison of Five Major Recent Endovascular Treatment Trials

Comparison of Five Major Recent Endovascular Treatment Trials Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline

More information

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Pak Heart J ORIGINAL ARTICLE PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Burhan Akhtar, Nauman Ali, Rana Kashif - Department Of Cardiology,

More information

Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth. May 23, 2018

Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth. May 23, 2018 Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth May 23, 2018 Disclosure No personal financial relationships with any company. Presentation Outline Definitions, signs

More information

Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital

Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for

More information

Recent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology

Recent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology Recent Changes in IV TPA Recommendations Ashish Masih, M.D Vascular Neurology Disclosures none 4 th leading cause of death Nearly 800,000 cases of stroke annually Statistics Leading cause of disability

More information